SCISPARC overview

NEW YORK, NY / ACCESSWIRE / July 7, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid cap publicly traded companies recently issued a new C-Level interview with SciSparc Ltd. Mark Roberts, Senior Editor at Traders News Source had the opportunity to conduct the interview featuring Oz Adler Chief Executive Officer at SciSparc. Mark recently conducted the Interview with Oz Adler CEO at SciSparc Ltd. (NASDAQ:SPRC). Mark diligently...

NEW YORK, NY / ACCESSWIRE / June 2, 2022 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $10 Million Private Placement Priced At-the-Market for SciSparc Ltd. (NASDAQ:SPRC). About SciSparc Ltd. SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. SciSparc's focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the Company is...